why choose us

First received: June 20, 2024

Clinical Trial: A Study to Learn About the Taste of Vericiguat Given in Liquid Form in Healthy Male Participants Aged 18 to 45 Years

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Heart Failure

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Single-blind, Randomized, 5-fold Crossover Taste Panel Study to Investigate the Taste Profile of an Oral Suspension of BAY 1021189 (Vericiguat) in Healthy Male Participants 18 to 45 Years o

Brief Summary: Heart failure is a condition in which the heart does not pump blood as well as it should.It can happen in both adults and children.The study treatment, vericiguat, also called BAY1021189, is already approved for doctors to give to adults who have heart failure, particularly those with an ejection fraction (EF) reduced to less than 45%.An EF is a measurement, expressed as a percentage, of how much blood is pumped with each heartbeat.An EF of less than 45% indicates a reduced ability of the heart to pump blood…

Read more